Pacer Trendpilot US Bond ETF (PTBD) Chart & Stock Price History → The #1 Opportunity of the decade? (From Behind the Markets) (Ad) Free PTBD Stock Alerts $19.88 -0.11 (-0.55%) (As of 04:38 PM ET) Add Compare Share Share ChartStock AnalysisChartDividendHoldingsOwnershipStock AnalysisChartDividendHoldingsOwnership Pacer Trendpilot US Bond ETF Stock Price Performance5 Day Performance-1.28%1 Month Performance-2.83%3 Month Performance-2.50%6 Month Performance+3.97%Year-To-Date Performance-2.88%1 Year Performance-0.45% Receive PTBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pacer Trendpilot US Bond ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsThe #1 Opportunity of the decade?It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.Click here to learn more >>> PTBD Stock Chart for Friday, April, 19, 2024 PTBD Chart by TradingView Pacer Trendpilot US Bond ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$19.98$19.99+0.08%$20.00$19.9550,179 shs$177.95 million04/17/2024$19.95$19.98+0.15%$20.03$19.966,998 shs$177.82 million04/16/2024$19.99$19.95-0.20%$20.02$19.9427,818 shs$177.56 million04/15/2024$20.14$19.99-0.73%$20.11$19.9741,047 shs$177.91 million04/12/2024$20.17$20.14-0.15%$20.15$20.0943,528 shs$179.25 million04/11/2024$20.17$20.17$20.20$20.0833,977 shs$199.68 million Get the Latest News and Ratings for PTBD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacer Trendpilot US Bond ETF and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$20.36$20.17-0.93%$20.23$20.1325,925 shs$199.68 million04/09/2024$20.31$20.36+0.25%$20.36$20.3142,873 shs$201.56 million04/08/2024$20.26$20.31+0.26%$20.32$20.2735,489 shs$201.07 million04/05/2024$20.27$20.26-0.06%$20.28$20.2519,473 shs$200.55 million04/04/2024$20.30$20.27-0.15%$20.37$20.2443,889 shs$200.67 million04/03/2024$20.26$20.30+0.20%$20.31$20.2433,517 shs$200.97 million04/02/2024$20.32$20.26-0.30%$20.26$20.2227,160 shs$200.57 million04/01/2024$20.40$20.32-0.37%$20.37$20.3059,675 shs$201.17 million03/29/2024$20.40$20.40-0.02%$20.44$20.3848,449 shs$201.91 million03/28/2024$20.33$20.40+0.34%$20.44$20.3848,449 shs$201.96 million03/27/2024$20.35$20.33-0.10%$20.43$20.3326,222 shs$201.27 million03/26/2024$20.38$20.35-0.15%$20.37$20.3342,464 shs$201.47 million03/25/2024$20.39$20.38-0.05%$20.41$20.3617,596 shs$201.76 million03/22/2024$20.43$20.39-0.20%$20.44$20.3814,808 shs$201.86 million03/21/2024$20.51$20.43-0.39%$20.47$20.3830,240 shs$202.26 million03/20/2024$20.46$20.51+0.24%$20.56$20.4456,952 shs$203.05 million03/19/2024$20.37$20.46+0.44%$20.48$20.3728,509 shs$202.55 million03/18/2024$20.35$20.37+0.10%$20.40$20.3632,592 shs$201.66 million03/15/2024$20.35$20.35$20.37$20.3327,160 shs$201.47 million03/14/2024$20.50$20.35-0.73%$20.45$20.3511,888 shs$201.47 million03/13/2024$20.44$20.50+0.29%$20.50$20.4445,379 shs$202.95 million03/12/2024$20.45$20.44-0.05%$20.47$20.4143,237 shs$202.36 million03/11/2024$20.45$20.45$20.48$20.4212,496 shs$202.46 million03/08/2024$20.44$20.45+0.05%$20.50$20.4249,460 shs$202.46 million03/07/2024$20.42$20.44+0.10%$20.46$20.4043,104 shs$202.36 million03/06/2024$20.35$20.42+0.34%$20.43$20.3915,407 shs$202.16 million03/05/2024$20.36$20.35-0.05%$20.40$20.3320,468 shs$201.47 million03/04/2024$20.39$20.36-0.15%$20.39$20.3421,451 shs$201.56 million03/01/2024$20.29$20.39+0.49%$20.39$20.2758,739 shs$201.86 million02/29/2024$20.26$20.29+0.15%$20.36$20.2726,948 shs$200.87 million02/28/2024$20.25$20.26+0.07%$20.28$20.2331,998 shs$200.57 million02/27/2024$20.27$20.25-0.12%$20.27$20.2172,627 shs$200.43 million02/26/2024$20.30$20.27-0.15%$20.32$20.2425,054 shs$200.67 million02/23/2024$20.27$20.30+0.15%$20.34$20.2825,273 shs$200.97 millionTiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>02/22/2024$20.30$20.27-0.15%$20.30$20.2524,114 shs$200.67 million02/21/2024$20.34$20.30-0.20%$20.33$20.2813,624 shs$200.97 million02/20/2024$20.30$20.34+0.20%$20.37$20.2814,774 shs$201.37 million02/19/2024$20.30$20.30$20.34$20.2919,200 shs$200.97 million02/16/2024$20.36$20.30-0.32%$20.34$20.2919,270 shs$200.92 million02/15/2024$20.30$20.36+0.32%$20.40$20.3323,183 shs$201.56 million02/14/2024$20.21$20.30+0.42%$20.33$20.2446,799 shs$200.92 million02/13/2024$20.40$20.21-0.93%$20.28$20.1919,397 shs$200.08 million02/12/2024$20.44$20.40-0.20%$20.47$20.3823,168 shs$201.96 million02/09/2024$20.38$20.44+0.29%$20.44$20.3621,260 shs$202.36 million02/08/2024$20.40$20.38-0.10%$20.42$20.3624,758 shs$201.76 million02/07/2024$20.34$20.40+0.29%$20.42$20.3330,895 shs$201.96 million02/06/2024$20.28$20.34+0.30%$20.35$20.2825,644 shs$201.37 million02/05/2024$20.36$20.28-0.40%$20.29$20.2522,186 shs$200.77 million02/02/2024$20.49$20.37-0.56%$20.41$20.3621,311 shs$201.66 million02/01/2024$20.35$20.49+0.66%$20.50$20.3237,961 shs$202.80 million01/31/2024$20.40$20.35-0.25%$20.46$20.3523,263 shs$201.47 million01/30/2024$20.45$20.40-0.24%$20.41$20.3722,208 shs$201.96 million01/29/2024$20.37$20.45+0.39%$20.49$20.3655,990 shs$202.46 million01/26/2024$20.38$20.37-0.05%$20.42$20.3336,146 shs$201.66 million01/25/2024$20.38$20.38$20.39$20.3124,690 shs$201.76 million01/24/2024$20.35$20.38+0.15%$20.45$20.3528,909 shs$201.76 million01/23/2024$20.38$20.35-0.15%$20.42$20.3441,842 shs$201.47 million01/22/2024$20.38$20.38$20.44$20.3721,613 shs$201.76 million01/19/2024$20.33$20.39+0.30%$20.39$20.2875,513 shs$201.86 million01/18/2024$20.32$20.33+0.05%$20.35$20.2818,773 shs$201.27 million Related Companies: CCOR Stock Chart IDMO Stock Chart MUSI Stock Chart EIS Stock Chart BYLD Stock Chart IMTB Stock Chart KBA Stock Chart GREK Stock Chart ARGT Stock Chart FLBR Stock Chart Receive PTBD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacer Trendpilot US Bond ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:PTBD) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacer Trendpilot US Bond ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.